──────────────────────────────
Patient Information:
──────────────────────────────
Name: Samuel Johnson
Medical Record Number: 990011223
Date of Birth: 06/20/1980 (Age: 45)
Gender: Male
Race: African American
Blood Type: B-
Primary Language: English
Marital Status: Divorced
Occupation: Bus Driver
Address: 78 Maple Street, Urban Heights, USA
Contact: (555) 123-0987

──────────────────────────────
Chief Complaint:
──────────────────────────────
Acute onset of severe pain in the left abdomen and difficulty breathing.

──────────────────────────────
History of Present Illness (HPI):
──────────────────────────────
Samuel presents with a sudden onset of left upper quadrant pain radiating to the back, accompanied by shortness of breath and fatigue. He has a known history of sickle cell disease with prior vaso-occlusive crises. He also reports a previous stroke two years ago with residual mild weakness on the right side.

──────────────────────────────
Past Medical History (PMH):
──────────────────────────────
• Sickle Cell Disease – Chronic hemolytic anemia with periodic pain crises.
• Asthma – Intermittent, managed with inhalers.
• History of Stroke – Occurred in 2021; residual mild right-sided weakness.

──────────────────────────────
Past Surgical History (PSH):
──────────────────────────────
• Splenectomy – 1995; complicated by post-surgical infection requiring extended hospitalization.

──────────────────────────────
Medications:
──────────────────────────────
• Hydroxyurea 500 mg daily
• Albuterol Inhaler as needed
• Low-dose Aspirin 81 mg daily
• Lisinopril 10 mg daily

──────────────────────────────
Allergies:
──────────────────────────────
• Sulfa Drugs – Causes rash and gastrointestinal upset

──────────────────────────────
Family History:
──────────────────────────────
• Mother: Sickle cell trait; history of anemia.
• Father: History of hypertension.

──────────────────────────────
Social History:
──────────────────────────────
• Tobacco: Denies use.
• Alcohol: Occasional beer.
• Employed full-time; lives alone; relies on community support during crises.

──────────────────────────────
Immunizations:
──────────────────────────────
• Influenza Vaccine annually
• Pneumococcal Vaccine post-splenectomy
• COVID-19: Fully vaccinated with booster in 2022

──────────────────────────────
Review of Systems:
──────────────────────────────
General: Fatigue and episodic pain crises.
Cardiovascular: No chest pain apart from current episode.
Respiratory: Occasional wheezing; current mild dyspnea.

──────────────────────────────
Physical Examination (Date: 11/25/2023):
──────────────────────────────
Vital Signs: BP 130/82 mmHg, HR 92 bpm, RR 20/min, Temp 99.1°F
General: Moderate distress due to pain.
Abdominal: Tenderness in the left upper quadrant; no rebound.
Respiratory: Clear lung fields.

──────────────────────────────
Laboratory Results:
──────────────────────────────
• CBC: Anemia with baseline low hemoglobin
• Reticulocyte count: Elevated
• Basic Metabolic Panel: Within acceptable limits

──────────────────────────────
Imaging and Diagnostic Studies:
──────────────────────────────
• Abdominal Ultrasound: Splenic bed absent; mild hepatomegaly noted.

──────────────────────────────
Hospital Course and Consultations:
──────────────────────────────
Admitted for vaso-occlusive pain management and evaluation of abdominal pain; hematology consulted to optimize sickle cell management.

──────────────────────────────
Assessment and Plan:
──────────────────────────────
1. Sickle Cell Crisis – Aggressive pain management, hydration, and oxygen therapy.
2. Asthma – Continue current inhaler regimen; monitor respiratory status.

──────────────────────────────
Follow-Up Appointments:
──────────────────────────────
• Hematology in 2 weeks
• Primary Care in 4 weeks

Physician’s Signature: Dr. Marcus Allen, MD
Date: 11/25/2023
